Figure 32

![Figure 32: Additional in vitro assay data supporting the anti-tumor effects of melatonin in enzalutamide-resistant prostate cancer cell lines.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Additional in vitro assay data supporting the anti-tumor effects of melatonin in enzalutamide-resistant prostate cancer cell lines." />
  <figcaption>Figure 32. Additional in vitro assay data supporting the anti-tumor effects of melatonin in enzalutamide-resistant prostate cancer cell lines.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>